欧洲肝病负担:流行病学与危险因素分析以确定预防政策
作为HEPAHEALTH项目的一部分,研究提取了世界卫生组织欧洲区域35个国家的肝病患病率、死亡率及其主要决定因素(酒精消费、肥胖、乙肝和丙肝病毒感染)的历史和当前数据,并识别针对这些危险因素的公共卫生干预措施。欧洲肝病流行病学多样,肝硬化和肝癌增加可能与北欧国家有害酒精消费急剧增加及东欧和南欧病毒性肝炎流行有关;鉴于多数欧洲国家肥胖率上升,历史上肝病水平较低的国家未来可能经历非酒精性脂肪性肝病增加。
要点
- 欧洲肝病负担持续增长,肝硬化和肝癌增加。
- 北欧肝硬化和肝癌增加可能与有害酒精消费急剧增加有关。
- 东欧和南欧肝硬化和肝癌增加可能与病毒性肝炎流行有关。
核心结论
- 欧洲肝病是严重问题,肝硬化和肝癌增加。
- 公共卫生和肝病学界应实施针对有害酒精消费、儿童和成人肥胖及肝炎病毒慢性感染的措施,以减少肝病负担。
研究设计与样本
- 作为HEPAHEALTH项目的一部分,从国家和国际文献及数据库提取世界卫生组织欧洲区域35个国家肝病的历史和当前患病率与死亡率信息。
- 提取酒精消费、肥胖及乙肝和丙肝病毒感染的历史和近期患病率数据。
- 从同行评议和灰色文献中提取信息,以识别针对这些危险因素的公共卫生干预措施。
主要发现
- 肝病流行病学多样,疾病确切构成和驱动其的危险因素趋势存在差异。
- 患病率和死亡率数据表明,肝硬化和肝癌增加可能与北欧国家有害酒精消费急剧增加有关。
- 患病率和死亡率数据表明,肝硬化和肝癌增加可能与东欧和南欧病毒性肝炎流行有关。
- 鉴于多数欧洲国家肥胖率上升,历史上肝病水平较低的国家未来可能经历非酒精性脂肪性肝病增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The burden of liver disease in Europe continues to grow. We aimed to describe the epidemiology of liver diseases and their risk factors in European countries, identifying public health interventions that could impact on these risk factors to reduce the burden of liver disease. As part of the HEPAHEALTH project we extracted information on historical and current prevalence and mortality from national and international literature and databases on liver disease in 35 countries in the World Health Organization European region, as well as historical and recent prevalence data on their main determinants; alcohol consumption, obesity and hepatitis B and C virus infections. We extracted information from peer-reviewed and grey literature to identify public health interventions targeting these risk factors. The epidemiology of liver disease is diverse, with variations in the exact composition of diseases and the trends in risk factors which drive them. Prevalence and mortality data indicate that increasing cirrhosis and liver cancer may be linked to dramatic increases in harmful alcohol consumption in Northern European countries, and viral hepatitis epidemics in Eastern and Southern European countries. Countries with historically low levels of liver disease may experience an increase in non-alcoholic fatty liver disease in the future, given the rise of obesity across most European countries. Liver disease in Europe is a serious issue, with increasing cirrhosis and liver cancer. The public health and hepatology communities are uniquely placed to implement measures aimed at reducing their causes: harmful alcohol consumption, child and adult obesity, and chronic infection with hepatitis viruses, which will in turn reduce the burden of liver disease.
引用
- Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018. PMID: 29777749. doi:10.1016/j.jhep.2018.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。